This transaction
Share acquisition (acquisition)The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Home healthcare services business
This has been reflected in the full-year consolidated earnings forecast for the fiscal year ending March 2026 announced on 4 February 2026.
| Item | Details |
|---|---|
| Transaction name | Share acquisition (acquisition) |
| Name of the Subject Company | Nippon Sanso Homecare España, S.L.U. (formerly Esteve Teijin Healthcare, S.L.) |
| Business Description of the Subject Company | Home healthcare services business |
| Location of the Subject Company | Castelldefels, Barcelona, Spain |
| Capital Stock of the Subject Company | €35.7 million |
| Date of Establishment of the Subject Company | February 2009 |
| Net Sales of the Subject Company | €40 million (¥6,503 million), fiscal year ended December 2024 |
| Operating Profit of the Subject Company | €3 million (¥509 million), fiscal year ended December 2024 |
| Net Income of the Subject Company | €2 million (¥306 million), fiscal year ended December 2024 |
| Net Assets of the Subject Company | €36 million (¥5,859 million), fiscal year ended December 2024 |
| Voting rights ownership percentage | After 100% (before not disclosed) |
| Impact on Business Performance | This has been reflected in the full-year consolidated earnings forecast for the fiscal year ending March 2026 announced on 4 February 2026. |
| Execution Date / Effective Date | 3 March 2026 (date on which the share acquisition procedures were completed) |
| Management structure after acquisition | The corporate name changed to "Nippon Sanso Homecare España, S.L.U." The representative is Director Justin Corcho (Mr.). Employee treatment: not disclosed. |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company agreed to acquire Esteve Teijin Healthcare, S.L., which operates a home healthcare services business in Spain, and completed the share acquisition on 3 March 2026. Subsequently, the Company reviewed the target company's historical capital transactions and determined that its stated capital amounted to 10% or more of the Company's stated capital, making it a specified subsidiary.